MRK US58933Y1055

Report

Real-time Estimate Cboe BZX - 08/03 01:58:16 pm
76.335	USD		+0.20%

07/30	MERCK : Goldman Sachs Adjusts Price Target for Merck to $104 From $102, Maintains Buy Rating	MT
07/30	MERCK : SVB Leerink Adjusts Price Target on Merck & Company to $101 From $99, Maintains Outperform Rating	MT
07/29	SECTOR UPDATE : Health Care Stocks Closing Slightly Higher	MT

Calendar

Event chart MERCK & CO., INC.

Upcoming events on MERCK & CO., INC.

09/14/21
10/28/21
10/28/21 \| 08:00am
02/03/22
05/03/22
07/29/22
10/27/22

Past events on MERCK & CO., INC.

07/29/21 \| 08:00am
07/29/21 \| 06:30am
07/18/21
07/18/21
07/18/21
07/18/21
07/18/21
07/18/21
07/18/21
07/18/21

Past dividends on MERCK & CO., INC.

06/14/21		Quarterly 0.65 USD
06/03/21		0
03/12/21		Quarterly 0.65 USD
12/14/20		Quarterly 0.65 USD
09/14/20		Quarterly 0.61 USD
06/12/20		Quarterly 0.61 USD
03/13/20		Quarterly 0.61 USD
12/13/19		Quarterly 0.61 USD
09/13/19		Quarterly 0.55 USD
06/14/19		Quarterly 0.55 USD

Annual results

Fiscal Period : December		2016	2017	2018	2019	2020	2021
Sales M $	Released Forecast Spread	39 807 39 991 -0,46%	40 122 40 205 -0,21%	42 294 42 234 0,14%	46 840 46 818 0,05%	47 994 48 177 -0,38%	46 932
Operating income (EBITDA) M $	Released Forecast Spread	19 154 19 083 0,37%	15 131 15 472 -2,2%	15 781 15 310 3,1%	19 572 18 761 4,3%	20 570 19 815 3,8%	18 724
Operating profit (EBIT) M $	Released Forecast Spread	13 713 13 698 0,11%	13 551 13 722 -1,2%	13 926 13 815 0,80%	15 920 16 276 -2,2%	16 945 17 366 -2,4%	16 708
Pre-Tax Profit (EBT) M $	Released Forecast Spread	7 499 7 288 2,9%	6 747 6 720 0,40%	8 701 8 296 4,9%	11 464 12 277 -6,6%	8 791 14 906 -41%	14 388
Net income M $	Released Forecast Spread	5 691 5 779 -1,5%	2 568 5 147 -50%	6 220 6 462 -3,7%	9 843 9 957 -1,1%	7 067 12 094 -42%	12 744
EPS $	Released Forecast Spread	2,04 2,03 0,57%	0,93 1,85 -50%	2,32 2,44 -5,0%	3,81 3,83 -0,52%	2,78 4,71 -41%	4,42
Announcement Date		02/02/2017	02/02/2018	02/01/2019	02/05/2020	02/04/2021	-

Quarterly results

Fiscal Period : December

2020 Q1

2020 Q2

2020 Q3

2020 Q4

2021 Q1

2021 Q2

Sales
M $

Released
Forecast
Spread

12 057
11 458
5,2%

10 872
10 657
2,0%

12 551
12 213
2,8%

12 514
12 668
-1,2%

12 080
12 648
-4,5%

11 193

Operating income
(EBITDA)
M $

Released
Forecast
Spread

4 802
4 715
1,8%

4 707
3 911
20%

5 744
4 862
18%

4 608
4 606
0,04%

5 220
5 416
-3,6%

4 555

Operating profit
(EBIT)
M $

Released
Forecast
Spread

3 981
4 205
-5,3%

3 659
3 238
13%

4 892
4 342
13%

3 704
4 047
-8,5%

4 290
4 844
-11%

4 032

Pre-Tax Profit
(EBT)
M $

Released
Forecast
Spread

3 367

Net income
M $

Released
Forecast
Spread

3 219
2 856
13%

3 002
2 323
29%

2 941
2 575
14%

-2 094
2 773
-176%

3 179
3 712
-14%

2 805

EPS
$

Released
Forecast
Spread

1,26
1,12
13%

1,18
0,91
29%

1,16
1,02
14%

-0,83
1,05
-179%

1,25
1,43
-13%

0,82

Announcement Date

04/28/2020

07/31/2020

10/27/2020

02/04/2021

04/29/2021

07/29/2021

Previous year

Next Year

Upcoming sector events for MERCK & CO., INC.

08/03/21		ELI LILLY AND COMPANY :
10/19/21		JOHNSON & JOHNSON :
10/20/21		ROCHE HOLDING AG :
10/26/21		NOVARTIS AG :
10/26/21		ELI LILLY AND COMPANY :
11/02/21		PFIZER, INC. :
01/25/22		JOHNSON & JOHNSON :
01/26/22		NOVARTIS AG :
02/01/22		PFIZER, INC. :
02/03/22		ELI LILLY AND COMPANY :

More events

Past sector events for MERCK & CO., INC.

07/28/21 \| 06:45am		PFIZER INC. :
07/22/21 \| 01:00am		ROCHE HOLDING AG :
07/21/21 \| 06:25am		JOHNSON & JOHNSON :
07/21/21		NOVARTIS AG :
05/04/21 \| 06:45am		PFIZER, INC. :
04/27/21 \| 06:25am		ELI LILLY AND COMPANY :
04/27/21		NOVARTIS AG :
04/21/21 \| 01:00am		ROCHE HOLDING AG :
04/20/21 \| 06:30am		JOHNSON & JOHNSON :
02/04/21 \| 01:00am		ROCHE HOLDING AG :

More events

Analysis

Exclusive-BlackRock backs 3 dissidents to shake up Exxon board -sources